Norway, Bill & Melinda Gates Foundation and the United Kingdom
In 2012, Norway, the Bill & Melinda Gates Foundation, and the UK committed to working together to increase the availability, access, and use of quality, life-saving family planning commodities, each committing US$200 million of their total Summit commitment until 2020 (a total of US$600 million). To ensure availability of high quality commodities in greatest demand, the partners pledged to deploy a range of market-shaping strategies with key players, such as multilateral agencies, manufacturers, partner governments, and the largest procurers to reduce prices, improve quality, minimize market risks, and improve value for money. The partners also committed to strengthening the quality of forecasting, streamlining regulatory pathways to reduce barriers to entry, and creating demand for improved new products. Innovative approaches such as mobile phone technology have been explored to ensure better access to meet demand from women, improve availability at the community level, and increase knowledge of family planning opportunities among women, families, and frontline health workers.
Implant Access Program: Expanding Family Planning Options for Women
A group of public and private organizations have collaborated to make Bayer’s Jadelle® and MSD’s Implanon NXT® available to women in the world’s poorest countries at price reductions of approximately 50% through 2018 (price reductions subsequently extended to 2023).